The global Bioengineered Skin Substitutes Market will register a 16.71% cagr in terms of revenue, the global market size will reach us$ 169.50 million by 2027.
The bioengineered skin substitutes market is currently in bloom, with juggernauts like AbbVie, Inc., Integra Biotherapeutics Corporation, Smith & Nephew plc, and Stryker Corporation, as well as other medium and small-medium enterprises, offering a diverse range of bioengineered skin substitutes products. Several businesses are attempting to break into the market and remain competitive by employing a variety of techniques ranging from partnerships and collaborations to corporate expansions and product releases.
This research report seeks to answer different elements of the global bioengineered skin replacements market with the help of key market drivers, restraints, and difficulties that may stifle overall market growth, as well as existing growth opportunities that will shape the industry's future trajectory. The research contains an in-depth analysis of the market's leading competitors as well as current trends. In addition, the study contains chapters on market dynamics (market drivers, opportunities, and challenges) as well as industry analyses.
Top key players in the Bioengineered Skin Substitutes market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Bioengineered Skin Substitutes market is fragmented with a large number of small players operating worldwide. The companies referred to in the market research report include Boston Scientific, Smith & Nephew, AbbVie Inc, Stryker Corporation, Anika Therapeutics Inc, Zimmer Biomet Holdings, Vericel Corporation, Integra LifeSciences, Aroa Biosurgery, Organogenesis Inc, Mölnlycke Health Care AB, AlloSource, Cook Biotech Incorporated, Promethean LifeSciences, ACell and other.
AbbVie Presents Positive Results from Phase 3 SELECT-AXIS 2 Trials of Upadacitinib (RINVOQ®) in Patients with Axial Spondyloarthritis at EULAR 2022
June 1, 2022 -- AbbVie (NYSE: ABBV) today announced the presentation of full results from two studies from the Phase 3 SELECT-AXIS 2 program evaluating upadacitinib (RINVOQ®), an oral therapy, in adult patients with active non-radiographic axial spondyloarthritis (nr-axSpA) and patients with treatment-refractory active ankylosing spondylitis (AS) with an inadequate response (IR) to biologic disease-modifying antirheumatic drugs (bDMARDs). Both studies met the primary endpoint of Assessment of SpondyloArthritis international Society 40 percent response criteria (ASAS40) at week 14 versus placebo.1,2
The market is segmented based on the type, applications, companies and regions.
By type, the Bioengineered Skin Substitutes Market has been segmented into
The end user’s industry application on the Bioengineered Skin Substitutes Market is,
Asia Pacific is predicted to develop at the fastest rate in the next years. A high prevalence of chronic diseases, big patient pools, and an increasing number of hospitals and healthcare facilities in the region with expanding infrastructure are all factors contributing to speedier emergence. Many overseas investors seek to expand their businesses in emerging markets such as India, China, and Singapore because of the region's enormous population base and significant unmet demands.
North america
The Bioengineered Skin Substitutes market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The global Bioengineered Skin Substitutes market report also conducted a pestel analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report attributes | Report details |
Report title | Bioengineered Skin Substitutes Market - global growth, trends and forecast (2022 - 2027) by types, by application, by regions and by key players: Boston Scientific, Smith & Nephew, AbbVie Inc, Stryker Corporation, Anika Therapeutics Inc |
Forecast period 2022 to 2028 cagr | Cagr of 16.71% over the forecast period (2022-2027) |
By type |
|
By application |
|
By companies | Boston Scientific, Smith & Nephew, AbbVie Inc, Stryker Corporation, Anika Therapeutics Inc, Zimmer Biomet Holdings, Vericel Corporation, Integra LifeSciences, Aroa Biosurgery, Organogenesis Inc, Mölnlycke Health Care AB, AlloSource, Cook Biotech Incorporated, Promethean LifeSciences, ACell |
Regions covered |
|
Countries covered |
|
Base year | 2022 |
Historical year | 2017 to 2021 |
Forecast year | 2022 to 2027 |
Number of pages | 119 |
Customization available | Yes, the report can be customized as per your needs |
What is the study period of this Market?
The Bioengineered Skin Substitutes market is studied from 2017 - 2027.
What is the growth rate of Bioengineered Skin Substitutes Market?
The Bioengineered Skin Substitutes market is growing at a cagr of 16.71% over the next 5 years.
Who are the key players in Bioengineered Skin Substitutes Market?
Boston Scientific, Smith & Nephew, AbbVie Inc, Stryker Corporation, Anika Therapeutics Inc, Zimmer Biomet Holdings, Vericel Corporation, Integra LifeSciences, Aroa Biosurgery, Organogenesis Inc, Mölnlycke Health Care AB, AlloSource, Cook Biotech Incorporated, Promethean LifeSciences, ACell
What regions does this Bioengineered Skin Substitutes Market report covers?
North america (the united states, canada, and mexico)
europe (germany, france, uk, russia, and italy)
asia-pacific (china, japan, korea, india, and southeast asia)
south america (brazil, argentina, colombia, etc.)
The middle east and africa (saudi arabia, uae, egypt, nigeria, and south africa)
What are the significant types of Bioengineered Skin Substitutes Market?
Modular, Integrated, Intensive Care Unit
What are the major end-use applications of the Bioengineered Skin Substitutes Market?
Hospitals, Outpatient Facilities, Ambulatory Surgical Centers (ASCs)
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.